Skip to main content
Supplement ScienceSupplementScience
Vinpocetine supplement
Cerebral Vasodilator

Vinpocetine — Research Profile

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Vinpocetine is a periwinkle-derived compound that selectively increases cerebral blood flow and has neuroprotective...

Vinpocetine is a periwinkle-derived compound that selectively increases cerebral blood flow and has neuroprotective properties. At 15-30mg daily it supports memory and cognitive function, particularly in cerebrovascular conditions. Widely prescribed in Europe as Cavinton.

Bottom line: Vinpocetine selectively boosts cerebral blood flow and has neuroprotective properties. Take 15-30mg daily with food — most evidence supports use in cerebrovascular conditions.

Evidence:Meta-analysis (2022) · 4 RCTs · n=601 · moderate confidence[#4]. See full reference list below.

Key Facts

What it is
A semi-synthetic periwinkle alkaloid that selectively enhances cerebral blood flow
Primary benefits
  • Selectively increases cerebral blood flow
  • Inhibits PDE1 for enhanced vasodilation
  • Neuroprotective anti-inflammatory effects
  • Supports memory in vascular cognitive impairment
  • Enhances glucose and oxygen utilization in the brain
Typical dosage
15-30mg daily
Evidence level
Moderate
Safety profile
Safe with Caution

Get the free evidence-based Vinpocetine guide — delivered in 60 seconds.

No spam. Unsubscribe anytime.

What the Research Says

Vinpocetine has been clinically utilized in Europe and Japan since the 1970s, primarily for cerebrovascular disorders. A 2003 Cochrane review by Szatmári and Whitehouse found evidence of cognitive benefits but noted that most trials were small and methodologically limited, emphasizing the need for larger, well-designed studies. The compound's selectivity for cerebral blood vessels is pharmacologically established, though its regulatory status in the US remains debated due to FDA questions about its classification as a dietary supplement ingredient.

Recent research has provided additional insights into vinpocetine's efficacy and safety. A 2022 systematic review and meta-analysis by Panda et al. (2022) of four randomized controlled trials involving 601 participants found that vinpocetine reduced disability in acute ischemic stroke patients at both 1 and 3 months compared to placebo, suggesting potential benefits for stroke recovery. However, earlier systematic reviews have yielded mixed results. Bereczki and Fekete (2008) reviewed two trials with a total of 70 participants and found no significant difference in death or dependency rates between vinpocetine and placebo for acute ischemic stroke. Similarly, a 1999 systematic review by the same authors (Bereczki & Fekete, 1999) of one small RCT also found no significant effect on case fatality or dependency.

Recent research has highlighted other potential benefits of vinpocetine. Zhang et al. (2018) reviewed its clinical use and recent discoveries, noting its anti-inflammatory and cardioprotective effects across various models, suggesting broader therapeutic applications beyond cerebrovascular disorders. Despite these advancements, the regulatory status of vinpocetine remains a topic of debate in the US, with questions about its classification as a dietary supplement ingredient (FDA). Further research is needed to establish definitive conclusions on its efficacy and safety across different conditions.

Benefits of Vinpocetine

  • Cerebral blood flow — vinpocetine selectively dilates cerebral blood vessels without significantly affecting systemic blood pressure, increasing oxygen and glucose delivery to brain tissue
  • Cognitive function — a 2003 Cochrane review identified several trials showing vinpocetine improved cognitive function in patients with cerebrovascular disease, though methodological quality was variable
  • Neuroprotection — vinpocetine inhibits neuronal voltage-dependent Na+ channels, reducing excitotoxic damage, and suppresses NF-κB-mediated neuroinflammation
  • PDE1 inhibition — by inhibiting phosphodiesterase type 1, vinpocetine increases cyclic GMP levels in vascular smooth muscle, promoting sustained cerebral vasodilation
  • Memory and learning — animal and human studies show improvements in memory consolidation and recall, particularly under conditions of reduced cerebral perfusion
Did you know?

Vinpocetine has been clinically utilized in Europe and Japan since the 1970s, primarily for cerebrovascular disorders.

Forms of Vinpocetine

Vinpocetine supplement forms compared by bioavailability and best use
FormBioavailabilityBest For
Vinpocetine Tablets (5-10mg)Moderate (enhanced with food)Standard dosing — take with fatty food to increase absorption by up to 60%
Vinpocetine Extended ReleaseModerateSustained effect — maintains steady blood levels throughout the day

Dosage Recommendations

General recommendation: 15-30mg daily, divided into 3 doses of 5-10mg with meals

Timing: Three times daily with meals containing fat for optimal absorption • Take with food for best absorption.

Dosage by Condition

Cognitive support
15-30mg daily in divided dosesModerate
Cerebrovascular support
30mg daily in divided dosesModerate
Tinnitus
15-30mg daily for 8+ weeksEmerging

Upper limit: 30mg/day (higher doses not well-studied in supplements)

Side Effects and Safety

Safety profile: Safe with Caution

Potential Side Effects

  • Generally well-tolerated at recommended doses
  • Mild headache or dizziness
  • Facial flushing
  • Nausea or stomach discomfort
  • Transient drop in blood pressure
  • Caution: FDA warned in 2019 that vinpocetine may be unsafe during pregnancy

Drug & Supplement Interactions

  • Anticoagulants and antiplatelets — vinpocetine may have mild antiplatelet effects
  • Blood pressure medications — additive hypotensive effects possible
  • CYP3A4 substrates — vinpocetine may affect metabolism of certain drugs
Check Vinpocetine interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

Commonly Taken Together

Related Guides

Related Supplements

Frequently Asked Questions

Is vinpocetine safe?

Vinpocetine has been used safely as a prescription medication in Europe for decades. At supplement doses of 15-30mg/day, serious side effects are rare. However, the FDA issued a warning in 2019 that vinpocetine may be unsafe during pregnancy due to potential effects on fetal development. It should also be used with caution alongside blood thinners.

How does vinpocetine differ from ginkgo biloba?

Both improve cerebral blood flow, but through different mechanisms. Vinpocetine selectively targets cerebral vasculature via PDE1 inhibition, while ginkgo works through PAF inhibition and antioxidant activity. Vinpocetine has a faster onset and more potent vasodilatory effect, while ginkgo has a broader antioxidant profile. They can be combined at lower doses of each.

Why must vinpocetine be taken with food?

Vinpocetine has low oral bioavailability on an empty stomach (about 7%). Taking it with food, especially fat-containing meals, increases absorption by up to 60-100%. This is because vinpocetine is lipophilic and requires bile salts for optimal intestinal absorption. Always take with meals for consistent effects.

What is the best form of Vinpocetine to take?

The best form of vinpocetine depends on your specific health goals, absorption needs, and tolerance. Chelated and standardized extract forms generally offer higher bioavailability than raw or unstandardized versions. Check the product label for third-party testing to ensure potency and purity.

What are the proven benefits of Vinpocetine?

Vinpocetine has been studied for multiple health applications with varying levels of clinical evidence. The strongest evidence typically comes from randomized controlled trials and meta-analyses published in peer-reviewed journals. Individual responses can vary based on baseline status, dosage, and duration of use.

Evidence:Meta-analysis (2022) · 4 RCTs · n=601 · moderate confidence[#4]. See full reference list below.

How much Vinpocetine should I take per day?

Vinpocetine dosage depends on the specific form, your health goals, and individual factors such as body weight and baseline nutrient status. Following the dose used in clinical trials is generally the most evidence-based approach. Starting at the lower end of the recommended range and adjusting upward is advisable.

When is the best time to take Vinpocetine?

Vinpocetine timing depends on whether it is fat-soluble or water-soluble and whether it causes digestive sensitivity. Consistency in timing is more important than the specific hour of the day. Taking supplements at the same time daily helps maintain steady levels.

What are the side effects of Vinpocetine?

Vinpocetine is generally well tolerated at recommended doses, with gastrointestinal discomfort being the most commonly reported side effect. Side effects are typically mild and dose-dependent, resolving with dose reduction or taking with food. Serious adverse effects are rare at standard supplemental doses.

Does Vinpocetine interact with any medications?

Vinpocetine may interact with certain prescription medications by affecting absorption, metabolism, or pharmacological effects. Always inform your healthcare provider about all supplements you take, especially before surgery or when starting new medications. Spacing supplements and medications by 2 hours reduces most absorption interactions.

Who should consider taking Vinpocetine?

Vinpocetine is most appropriate for individuals with confirmed deficiency, suboptimal levels, or specific health conditions supported by clinical evidence. People in higher-risk demographics, including older adults and those with restricted diets, may benefit most. Testing baseline levels before supplementing provides the best guidance.

How long does Vinpocetine take to show results?

Vinpocetine effects vary by the specific health outcome being targeted, with some benefits appearing within days and others requiring weeks to months of consistent daily use. Correcting a deficiency typically shows improvement within 2-4 weeks. A minimum 8-12 week trial at the recommended dose is advisable before evaluating effectiveness.

Is Vinpocetine safe for long-term daily use?

Vinpocetine is considered safe for long-term use at recommended doses based on available clinical data. Staying within established upper intake limits minimizes the risk of adverse effects over time. Periodic reassessment with a healthcare provider is recommended, especially if health conditions change.

Can you take too much Vinpocetine?

Exceeding the recommended dose of vinpocetine increases the risk of adverse effects without providing additional benefit. Toxicity risk varies by form and individual factors such as kidney and liver function. Mega-dosing is not supported by clinical evidence and should be avoided.

Can I combine Vinpocetine with other supplements?

Vinpocetine can generally be combined with complementary supplements, though some combinations may affect absorption or create additive effects. Spacing different supplements by 1-2 hours can reduce absorption competition. Consulting a healthcare professional is advisable when combining multiple supplements targeting the same health pathway.

What should I look for when buying a Vinpocetine supplement?

Third-party testing from USP, NSF, or ConsumerLab is the most important quality indicator when purchasing vinpocetine supplements. Look for products that clearly state the specific form, dose per serving, and any relevant standardization percentages. Avoid proprietary blends that hide individual ingredient amounts.

Continue Reading

References

  1. ReviewSzatmári S, Whitehouse P (2003). Vinpocetine for cognitive impairment and dementia. Cochrane Database of Systematic Reviews. DOI PubMed
  2. ReviewZhang YS, Li JD, Yan C (2018). An update on vinpocetine: new discoveries and clinical implications. European Journal of Pharmacology. DOI PubMed
  3. Meta-analysisPanda PK, Ramachandran A, Panda P, Sharawat IK (2022). Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.. Neurocritical care. DOI PubMed
  4. Meta-analysisBereczki D, Fekete I (2008). Vinpocetine for acute ischaemic stroke.. The Cochrane database of systematic reviews. DOI PubMed
  5. RCTBereczki D, Fekete I (2000). Vinpocetine for acute ischaemic stroke.. The Cochrane database of systematic reviews. DOI PubMed
  6. ReviewBereczki D, Fekete I (1999). A systematic review of vinpocetine therapy in acute ischaemic stroke.. European journal of clinical pharmacology. DOI PubMed
  7. ReviewBagoly E, Fehér G, Szapáry L (2007). [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].. Orvosi hetilap. DOI PubMed
Show 1 more reference
  1. Wang KN, Bell JS, Chen EYH, Gilmartin-Thomas JFM, et al. (2018). Medications and Prescribing Patterns as Factors Associated with Hospitalizations from Long-Term Care Facilities: A Systematic Review.. Drugs & aging. DOI PubMed